Alkermes (ALKS) Tops Q4 EPS by 39c, Offers Mixed FY Guidance

Alkermes (NASDAQ: ALKS) reported Q4 EPS of $0.34, $0.39 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $315.8 million versus the consensus estimate of $255.09 million.

GUIDANCE:

Alkermes sees FY2019 EPS of $0.25-$0.43, versus the consensus of $0.56. Alkermes sees FY2019 revenue of $1.14-1.19 billion, versus the consensus of $1.1 billion.

For earnings history and earnings-related data on Alkermes (ALKS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance